Akemi Nogiwa 30/06/2023 Akemi Nogiwa 30/06/2023

Prof. Molly Stevens shortlisted for AF Harvey Engineering Research Prize

Molly is among the six world-leading scientists shortlisted as nominees for the prestigious AF Harvey Engineering Research Prize.

Akemi Nogiwa 23/04/2023 Akemi Nogiwa 23/04/2023

Prof. Molly Stevens receives 2023 Novo Nordisk Prize

Molly was awarded the 2023 Novo Nordisk Prize in recognition of her pioneering work in innovative bioengineering approaches.

Akemi Nogiwa 28/02/2023 Akemi Nogiwa 28/02/2023

Prof Molly Stevens wins 2023 Novo Nordisk Prize

Molly was awarded the 2023 Novo Nordisk Prize in recognition of her pioneering work in innovative bioengineering approaches.

Akemi Nogiwa 07/11/2022 Akemi Nogiwa 07/11/2022

Stevens Group participates in international research consortium “Supervised Morphogenesis in Gastruloids - SUMO”

The Stevens Group will participate in an interdisciplinary project focused on the development of realistic in vitro organ models (organoids) by building on state-of-the-art gastruloid technology.

Akemi Nogiwa 30/09/2022 Akemi Nogiwa 30/09/2022

Virustatic nanoparticles paper published in ACS Central Science

Our synthetic polymer-lipid nanoparticles mimic functional components of host cell membranes, tricking viruses and parasites into binding to the particles instead of the host cells.

Akemi Nogiwa 30/09/2022 Akemi Nogiwa 30/09/2022

Microrobotics paper published in Advanced Materials

Our puff-ball inspired microrobotic system combines high cargo loading, strong cargo protection, on-demand cargo release and magnetic-guided locomotion towards an exceptional control over drug delivery.

Akemi Nogiwa 31/08/2022 Akemi Nogiwa 31/08/2022

Paper on artificial cells published in Nature Chemistry

This work showcases the implementation of light-modulated communication processes between artificial cells based on polymer-enzyme ensembles to achieve homeostasis as one of the hallmarks of life.

Akemi Nogiwa 31/08/2022 Akemi Nogiwa 31/08/2022

CrisprZyme paper published in Nature Nanotechnology

CrisprZyme combines CRISPR-Cas and catalytic metallic nanoparticles into an ultra-sensitive and versatile diagnostic platform for the detection of ncRNA.

Akemi Nogiwa 31/08/2022 Akemi Nogiwa 31/08/2022

Commentary paper on semi-synthetic biomaterials published in Nature Materials

Semi-synthetic goldilocks material design integrates the tunable characteristics of synthetic materials and the refined complexity of natural components, enabling for the progress of biomaterials across length scales.